Effects of Electroacupuncture plus dopamine D1 receptor antagonist on somatosensory evoked potentials and behavioral changes in rats with cerebral ischemia-reperfusion

Journal of Acupuncture and Tuina Science ◽

10.1007/s11726-012-0589-6 ◽

2012 ◽

Vol 10 (3) ◽

pp. 133-137 ◽

Author(s):

Cheng-yong Liu ◽

Ming-shu Xu ◽

Lin-bao Ge

Keyword(s):

Cerebral Ischemia ◽

Evoked Potentials ◽

Receptor Antagonist ◽

Somatosensory Evoked Potentials ◽

Ischemia Reperfusion ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Behavioral Changes ◽

Cerebral Ischemia Reperfusion ◽

D1 Receptor Antagonist

Download Full-text

Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity

Naunyn-Schmiedeberg s Archives of Pharmacology ◽

10.1007/s00210-019-01694-3 ◽

2019 ◽

Vol 393 (1) ◽

pp. 131-138 ◽

Author(s):

Sun Mi Gu ◽

Hye Jin Cha ◽

So Woon Seo ◽

Jin Tae Hong ◽

Jaesuk Yun

Keyword(s):

Receptor Antagonist ◽

Dopamine Receptor ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Receptor Supersensitivity ◽

Dopamine Receptor Supersensitivity ◽

Conditioned Place Preferences ◽

Place Preferences ◽

D1 Receptor Antagonist

Download Full-text

Selective alterations of the first NREM sleep cycle in humans by a dopamine D1 receptor antagonist (NNC-687)

Journal of Psychiatric Research ◽

10.1016/s0022-3956(03)00007-4 ◽

2003 ◽

Vol 37 (4) ◽

pp. 305-312 ◽

Author(s):

Derek N. Eder ◽

Milan Zdravkovic ◽

Gordon Wildschiødtz

Keyword(s):

Receptor Antagonist ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Sleep Cycle ◽

D1 Receptor Antagonist

Download Full-text

A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2016.04.012 ◽

2016 ◽

Vol 118 (3) ◽

pp. 160-166 ◽

Author(s):

Tanya Khasnavis ◽

Rosa J. Torres ◽

Barbara Sommerfeld ◽

Juan Garcia Puig ◽

Richard Chipkin ◽

...

Keyword(s):

Receptor Antagonist ◽

Crossover Trial ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Selective Dopamine ◽

D1 Receptor Antagonist

Download Full-text

Effects of the dopamine D1 receptor antagonist SCH23390 on self-administration of cocaine and fentanyl by rats trained on a progressive ratio reinforcement schedule.

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)50372-9 ◽

1994 ◽

Vol 64 ◽

pp. 182

Author(s):

Yasuyuki Awasaki ◽

Nobuyuki Nishida ◽

Satoshi Sasaki ◽

Shuzo Sato

Keyword(s):

Receptor Antagonist ◽

Reinforcement Schedule ◽

Progressive Ratio ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Self Administration ◽

D1 Receptor Antagonist

Download Full-text

The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons

Neuroscience Letters ◽

10.1016/0304-3940(95)12025-y ◽

1995 ◽

Vol 199 (1) ◽

pp. 13-16 ◽

Author(s):

Stephen R. Wachtel ◽

Francis J. White

Keyword(s):

Nucleus Accumbens ◽

Receptor Antagonist ◽

Sch 23390 ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Rat Nucleus Accumbens ◽

D1 Receptor Antagonist

Download Full-text

A dopamine D1 receptor antagonist, SCH 23390, selectively blocks vasopressin release after noxious stimuli in the rat

Neuroscience Letters ◽

10.1016/0304-3940(92)90038-9 ◽

1992 ◽

Vol 136 (2) ◽

pp. 157-160 ◽

Author(s):

Tatsushi Onaka ◽

Hidetaka Torigoe ◽

Kinji Yagi

Keyword(s):

Receptor Antagonist ◽

Sch 23390 ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Vasopressin Release ◽

Noxious Stimuli ◽

D1 Receptor Antagonist

Download Full-text

THuNDRous news for human dopamine researchers: A selective dopamine D1 receptor antagonist will soon be available for clinical research

Journal of Psychopharmacology ◽

10.1177/0269881118799380 ◽

2018 ◽

Vol 32 (11) ◽

pp. 1153-1154 ◽

Author(s):

David Nutt ◽

Trevor Robbins ◽

Ann Hayes

Keyword(s):

Clinical Research ◽

Receptor Antagonist ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Selective Dopamine ◽

D1 Receptor Antagonist

Download Full-text

Dopamine D1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice

Pharmacology Biochemistry and Behavior ◽

10.1016/0091-3057(95)00173-t ◽

1995 ◽

Vol 52 (4) ◽

pp. 759-763 ◽

Author(s):

Hisashi Kuribara

Keyword(s):

Receptor Antagonist ◽

Sch 23390 ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Combined Administration ◽

D1 Receptor Antagonist

Download Full-text

Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm

Brain Research ◽

10.1016/s0006-8993(98)00281-9 ◽

1998 ◽

Vol 795 (1-2) ◽

pp. 128-136 ◽

Author(s):

Elaine Waddington Lamont ◽

Larry Kokkinidis

Keyword(s):

Receptor Antagonist ◽

Sch 23390 ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Fear Expression ◽

D1 Receptor Antagonist

Download Full-text

The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors

European Journal of Pharmacology ◽

10.1016/s0014-2999(98)00825-5 ◽

1999 ◽

Vol 364 (1) ◽

pp. 33-41 ◽

Author(s):

Gerda Andringa ◽

Benjamin Drukarch ◽

Josée E. Leysen ◽

Alexander R. Cools ◽

Johannes C. Stoof

Keyword(s):

Receptor Antagonist ◽

Receptor Agonist ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

D1 Receptor Antagonist

Download Full-text